词条 | Episcleritis |
释义 |
| name = Episcleritis | synonyms = | image = episcleritiseye.jpg | caption = Eye with Episcleritis | pronounce = | field = Ophthalmology | symptoms = | complications = | onset = | duration = | types = | causes = | risks = | diagnosis = | differential = | prevention = | treatment = | medication = | prognosis = | frequency = | deaths = }} Episcleritis is a benign, self-limiting inflammatory disease affecting part of the eye called the episclera. The episclera is a thin layer of tissue that lies between the conjunctiva and the connective tissue layer that forms the white of the eye (sclera). Episcleritis is a common condition, and is characterized by the abrupt onset of painless eye redness. There are two types of episcleritis, nodular and simple. Nodular episcleritis lesions have raised surface. Simple episcleritis lesions are flat. There are two subtypes. In diffuse simple episcleritis, inflammation is generalized. In sectoral simple episcleritis, the inflammation is restricted to one region. Most cases of episcleritis have no identifiable cause, although a small fraction of cases is associated with various systemic diseases. Often people with episcleritis experience it recurrently. Treatment focuses on decreasing discomfort, and includes lubricating eye drops. More severe cases may be treated with topical corticosteroids or oral anti-inflammatory medications (NSAIDs). Signs and symptomsSymptoms of episcleritis typically include painless redness of the eye (mild pain is possible but atypical), and watery eyes.[1] The pain of episcleritis is typically mild, less severe than in scleritis,[2] and may be tender to palpation.[3] There are two types of episcleritis: the diffuse type, where the redness involves the entire episclera, and the nodular type, where the redness appears more nodular, involving only a small, well-circumscribed area (sectoral).[4] The diffuse type of episcleritis may be less painful than the nodular type. Sometimes, small nodules are present within the episclera, which move slightly over the sclera with gentle pressure.[4] Discharge is absent with episcleritis, and vision is unaffected.[4] Patients with episcleritis experience far less photophobia than patients with uveitis.[1] Episcleritis does not cause the presence of cells or flare in the anterior chamber of the eye.[1] PathophysiologyMost of the time, the cause of episcleritis is never determined (idiopathic). An identifiable cause is discovered in about one third of cases.[5] Several diseases are associated with episcleritis, including systemic vasculitic diseases (polyarteritis nodosa, granulomatosis with polyangiitis), connective tissue diseases (rheumatoid arthritis),[6] rosacea, atopy,[5] gout,[4] and ulcerative colitis.[7] 59 percent of patients with relapsing polychondritis have either episcleritis or scleritis.[8] Rarely, episcleritis may be caused by scleritis.[9] The redness in the eye associated with episcleritis is due to engorgement of the large episcleral blood vessels, which run in a radial direction from the limbus.[4] Typically, there is no uveitis, or thickening of the sclera. DiagnosisThe diagnosis of episcleritis is based upon the history and physical examination. The history should be explored for the presence of the diseases associated with episcleritis, and the symptoms they cause, such as rash, arthritis, venereal disease, and recent viral infection.[4] Episcleritis may be differentiated from scleritis by using phenylephrine or neosynephrine eye drops, which causes blanching of the blood vessels in episcleritis, but not in scleritis.[2] A blue color to the sclera suggests scleritis, rather than episcleritis. After anesthetizing the eye with medication, the conjunctiva may be moved with a cotton swab to observe the location of the enlarged blood vessels. TreatmentOften, treatment is not necessary, because episcleritis is a self-limiting condition. Artificial tears may be used to help with irritation and discomfort. More severe cases can be treated with either topical corticosteroids or oral non-steroidal anti-inflammatory drugs.[5] Ketorolac, a topical NSAID, may be used, but it is not more effective than artificial tears and it causes more side effects.[10]PrognosisEpiscleritis is a benign, self-limiting condition, meaning patients recover without any treatment. Most cases of episcleritis resolve within 7–10 days.[1] The nodular type is more aggressive and takes longer to resolve.[1] Although rare, some cases may progress to scleritis.[23] However, in general, episcleritis does not cause complications in the eye.[11] Smoking tobacco delays the response to treatment in patients with episcleritis.[12] EpidemiologyEpiscleritis is a common disease,[13] and its exact prevalence and incidence are unknown. It typically affects young adults,[13] and may be more common in women. References1. ^1 2 3 4 {{cite journal |last=Heath |first=Greg |title=The episclera, sclera and conjunctiva An overview of relevant ocular anatomy |journal=OT |date=10 February 2010 |url=http://www.optometry.co.uk/uploads/articles/2968dcb27c990328d028d328b5c649b5_CETheath-10206.pdf |pages=36–42 |accessdate=30 November 2012 |deadurl=yes |archiveurl=https://web.archive.org/web/20130513025206/http://www.optometry.co.uk/uploads/articles/2968dcb27c990328d028d328b5c649b5_CETheath-10206.pdf |archivedate=13 May 2013 |df= }} 2. ^1 {{cite book |last=Goldman |first=Lee |title=Goldman's Cecil Medicine |publisher=Elsevier Saunders |location=Philadelphia |isbn=978-1437727883 |year=2011 |pages=2440 |edition=24th}} 3. ^{{cite book |author=Chumley H. |author2=Usatine RP |author3=Smith MA |author4=Chumley H |author5=Mayeaux, Jr. E |author6=Tysinger J |title=The Color Atlas of Family Medicine: Chapter 16. Scleritis and Episcleritis. |year=2009 |publisher=McGraw-Hill Education Medical |location=New York |isbn=978-0071769648 |url=http://www.accessmedicine.com/content.aspx?aID=8200829 |edition=2nd}} 4. ^1 2 3 4 5 {{cite book |last=Kunimoto |first=Derek |author2=Kunal Kanitkar |author3=Mary Makar |title=The Wills eye manual: office and emergency room diagnosis and treatment of eye disease. |year=2004 |publisher=Lippincott Williams & Wilkins |location=Philadelphia, PA |isbn=978-0781742078 |pages=99–100 |edition=4}} 5. ^1 2 {{cite book |last=Yanoff |first=Myron |author2=Jay S. Duker |title=Ophthalmology |year=2008 |publisher=Mosby |location=Edinburgh |isbn=978-0323057516 |pages=255–261 |edition=3rd}} 6. ^{{cite journal |last=Watson |first=PG |author2=Hayreh, SS |title=Scleritis and episcleritis. |journal=The British Journal of Ophthalmology |date=March 1976 |volume=60 |issue=3 |pages=163–91 |pmid=1268179 |doi=10.1136/bjo.60.3.163 |pmc=1042706}} 7. ^{{cite journal |last=Langholz |first=E. |title=Review: Current trends in inflammatory bowel disease: the natural history |journal=Therapeutic Advances in Gastroenterology |date=March 2010 |volume=3 |issue=2 |pages=77–86 |doi=10.1177/1756283X10361304 |pmid=21180592 |pmc=3002570}} 8. ^{{cite book |last=Sabatine |first=Marc S. |title=Pocket Medicine |year=2011 |publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins |location=Philadelphia |isbn=978-1608319053 |page=8–4 |edition=4th}} 9. ^{{cite web |url=https://www.nlm.nih.gov/medlineplus/ency/article/001019.htm |title=Episcleritis: MedlinePlus Medical Encyclopedia |publisher=United States National Library of Medicine |accessdate=20 June 2010 |location=Bethesda, MD}} 10. ^{{cite journal |last=Williams |first=CP |author2=Browning, AC |author3=Sleep, TJ |author4=Webber, SK |author5=McGill, JI |title=A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis. |journal=Eye (London, England) |date=July 2005 |volume=19 |issue=7 |pages=739–42 |pmid=15359265 |doi=10.1038/sj.eye.6701632}} 11. ^1 {{cite journal |last=Jabs |first=Douglas A. |author2=Mudun, Abdulbaki |author3=Dunn, J.P. |author4=Marsh, Marta J. |title=Episcleritis and scleritis: clinical features and treatment results |journal=American Journal of Ophthalmology |date=Oct 2000 |volume=130 |issue=4 |pages=469–476 |doi=10.1016/S0002-9394(00)00710-8 |pmid=11024419 |url=http://www.sciencedirect.com/science/article/pii/S0002939400007108 |accessdate=30 November 2012}} 12. ^{{cite journal |last=Boonman |first=Z F H M |last2=de Keizer |first2=R J W |last3=Watson |first3=P G |title=Smoking delays the response to treatment in episcleritis and scleritis |journal=Eye |date=September 2005 |volume=19 |issue=9 |pages=949–955 |doi=10.1038/sj.eye.6701731 |pmid=15543188}} 13. ^1 {{cite book |author=Levsky M.E. |author2=DeFlorio P. |title=Atlas of emergency medicine: Chapter 2 Ophthalmologic Conditions. |year=2010 |publisher=McGraw-Hill Professional |location=New York |isbn=978-0071496186 |url=http://www.accessmedicine.com/content.aspx?aID=6000227 |edition=3rd}} External links{{Medical resources| DiseasesDB = 4375 | ICD10 = {{ICD10|H|15|1|h|15}} | ICD9 = {{ICD9|379.0}} | ICDO = | OMIM = | MedlinePlus = 001019 | MedlinePlus_mult= | eMedicineSubj = | eMedicineTopic = | eMedicine_mult = | MeshID = D015423 }}{{Eye pathology}}{{Inflammation}} 2 : Disorders of sclera and cornea|Inflammations |
随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。